Form D · Pharmaceuticals
MindImmune Therapeutics, Inc.
Kingston, RI · CIK 0001792522
Offering snapshot reported Mar 5, 2026 · SEC filing
- Reported sold
- $15.2M Offering amount: $17M
- Investors reported
- 15 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 24, 2025 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$10,203,858 → $15,218,343
- Reported investors14 → 15
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 5, 2026 | Amendment | $15,218,343 | $5,014,485vs Dec 5, 2025 | 15 | SEC filing |
| Dec 5, 2025 | Initial | $10,203,858 | No comparison | 14 | SEC filing |
| Feb 4, 2022 | Initial | $5,349,999 | No comparison | 12 | SEC filing |
| Nov 1, 2019 | Initial | $750,000 | No comparison | 8 | SEC filing |
Offering details
- Securities
- Equity, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-565904
The Issuer also converted previously issued promissory notes valued at $7,731,294 into shares of its Series A-3(A) Preferred Stock.
Source: Form D, filed Mar 5, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Reetika Bhardwaj | Director |
| Diane Gooding | Executive |
| Richard G. Horan | Director |
| Bradley Margus | Director |
| Frank S. Menniti | Director, Executive |
| Robert Nelson | Executive |
| Christopher O'donnell | Director |
| Tracy Saxton | Director |
| Isaac Stoner | Director, Executive |
| Stevin Zorn | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:Kingston, RI, 02881
Phone: 401-225-4612